Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose EPInephrine to Improve Platelet Reactivity in TICagrelor-treated Subjects: A Proof of Concept Study in Healthy Volunteers (EPITIC)

NCT03441412 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT03441412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03441412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose EPInephrine to Improve Platelet Reactivity in TICagrelor-treated Subjects: A Proof of Concept Study in Healthy Volunteers (EPITIC)
Lead sponsor
Vastra Gotaland Region
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2018
Completion date
March 28, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers